![Patrick C. Hutchison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick C. Hutchison
Treasurer presso
TETRALOGIC PHARMACEUTICALS CORPORATION
Profilo
Mr. Patrick C.
Hutchison, CPA, is a Co-Founder, Partner at Boundary Street Capital LP, a Treasurer at TetraLogic Pharmaceuticals Corp.
and a Managing Director at Stonepeak Partners LP.
Mr. Hutchison was previously employed as a Chief Financial Officer by BioSpecifics Technologies Corp., a Chief Financial Officer by SwanBio Therapeutics, Inc., a Chief Financial Officer by Innocoll Holdings Plc, a Chief Financial Officer by Innocoll, Inc., a Vice President by Pacific Western Asset Management, Inc., a Chief Accounting Officer & VP-Corporate Controller by Teleflex, Inc., a Vice President by MCG Capital, a Controller by Cephalon, Inc., a Principal by Day & Zimmermann, Inc. (Pennsylvania), a Chief Financial Officer by InfraScan, Inc., and a Principal by Pierce Leahy Corp.
He received his undergraduate degree from the University of Pennsylvania.
Posizioni attive di Patrick C. Hutchison
| Società | Posizione | Inizio |
|---|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Treasurer | 30/04/2016 |
Boundary Street Capital LP
 Boundary Street Capital LP Investment ManagersFinance Boundary Street Capital invests in lower middle market companies located in the United States with revenues of USD 5 – 50 million. The firm targets companies operating in the fields of digital infrastructure, digital services and enterprise software sectors. It provides financing for buyout transactions. Boundary Street Capital was acquired by Stonepeak on January 16, 2025, subsequently transitioning its operations by integrating its digital infrastructure and technology credit funds into an expanded segment called Stonepeak Credit. | Fondatore | 01/01/2018 |
Precedenti posizioni note di Patrick C. Hutchison
| Società | Posizione | Fine |
|---|---|---|
| BIOSPECIFICS TECHNOLOGIES CORP. | Direttore Finanziario/CFO | 02/12/2020 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Direttore Finanziario/CFO | 01/12/2019 |
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products and medical devices | Direttore Finanziario/CFO | 01/08/2018 |
Pacific Western Asset Management, Inc.
 Pacific Western Asset Management, Inc. Investment ManagersFinance Provides investment advice | Investitore di Private Equity | 31/12/2017 |
MCG Capital
 MCG Capital Investment ManagersFinance MCG Capital provides capital to support the growth and value creation strategies of small- to mid-sized companies. They invest in companies with $20 million to $200 million in revenue and $3 million to $25 million in EBITDA. The firm looks for companies with the following characteristics: proven business models, stable customer bases, operating leverage, barriers to entry, defensible market shares and quality management teams. They avoid highly cyclical and volatile industry sectors and businesses with extraordinary volatility exposure. | Investitore di Private Equity | 31/03/2014 |
Formazione di Patrick C. Hutchison
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Teleflex, Inc.
 Teleflex, Inc. Medical SpecialtiesHealth Technology Provides medical devices for critical care, urology and surgery | Health Technology |
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Pierce Leahy Corp.
 Pierce Leahy Corp. Other TransportationTransportation Record storage | Transportation |
InfraScan, Inc.
 InfraScan, Inc. Medical SpecialtiesHealth Technology Develops and distributes diagnostic imaging devices | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MCG Capital
MCG Capital Investment ManagersFinance MCG Capital provides capital to support the growth and value creation strategies of small- to mid-sized companies. They invest in companies with $20 million to $200 million in revenue and $3 million to $25 million in EBITDA. The firm looks for companies with the following characteristics: proven business models, stable customer bases, operating leverage, barriers to entry, defensible market shares and quality management teams. They avoid highly cyclical and volatile industry sectors and businesses with extraordinary volatility exposure. | Finance |
Day & Zimmermann, Inc. (Pennsylvania)
 Day & Zimmermann, Inc. (Pennsylvania) Engineering & ConstructionIndustrial Services Provides engineering, architecture and facilities support services | Industrial Services |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products and medical devices | Health Technology |
Pacific Western Asset Management, Inc.
Pacific Western Asset Management, Inc. Investment ManagersFinance Provides investment advice | Finance |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Boundary Street Capital LP
Boundary Street Capital LP Investment ManagersFinance Boundary Street Capital invests in lower middle market companies located in the United States with revenues of USD 5 – 50 million. The firm targets companies operating in the fields of digital infrastructure, digital services and enterprise software sectors. It provides financing for buyout transactions. Boundary Street Capital was acquired by Stonepeak on January 16, 2025, subsequently transitioning its operations by integrating its digital infrastructure and technology credit funds into an expanded segment called Stonepeak Credit. | Finance |
